Partner, Lightspeed Venture Partners

With over three decades of experience in the life science and healthcare sectors, Dr. MacQuitty is nothing if not analytical—as a Venture Partner at Lightspeed, as a competitive bridge player, as initial CEO of Forty Seven Inc. and D2G Oncology Inc. Formerly, Dr. MacQuitty was founding CEO of GenPharm International, a venture-backed Bay Area biotech company developing a human sequence antibody platform. After 10 years there, he moved into his first venture capital role as partner and head of the West Coast office of Abingworth, a trans-Atlantic life science venture capital firm.

BACK TO TEAM